These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28733272)

  • 1. Adherence to Web-Based Self-Assessments in Long-Term Direct-to-Patient Research: Two-Year Study of Multiple Sclerosis Patients.
    Jongen PJ; Kremer IEH; Hristodorova E; Evers SMAA; Kool A; van Noort EM; Hiligsmann M
    J Med Internet Res; 2017 Jul; 19(7):e249. PubMed ID: 28733272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol.
    Jongen PJ; Heerings M; Lemmens WA; Donders R; van der Zande A; van Noort E; Kool A
    BMC Neurol; 2015 Aug; 15():128. PubMed ID: 26238866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
    Jongen PJ; Blok BF; Heesakkers JP; Heerings M; Lemmens WA; Donders R
    Health Qual Life Outcomes; 2015 Oct; 13():175. PubMed ID: 26518712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Italian multiple sclerosis quality of life 54 questionnaire.
    Solari A; Filippini G; Mendozzi L; Ghezzi A; Cifani S; Barbieri E; Baldini S; Salmaggi A; Mantia LL; Farinotti M; Caputo D; Mosconi P
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):158-62. PubMed ID: 10406981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study).
    Jongen PJ; Lemmens WA; Hoogervorst EL; Donders R
    Health Qual Life Outcomes; 2017 Mar; 15(1):50. PubMed ID: 28292329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS).
    Twork S; Wiesmeth S; Spindler M; Wirtz M; Schipper S; Pöhlau D; Klewer J; Kugler J
    Health Qual Life Outcomes; 2010 Jun; 8():55. PubMed ID: 20529265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).
    Jongen PJ; Hengstman G; Hupperts R; Schrijver H; Gilhuis J; Vliegen JH; Hoogervorst E; van Huizen M; van Munster E; Samijn J; de Schryver E; Siepman T; Tonk M; Zandbergen E; ten Holter J; van der Kruijk R; Borm G
    BMC Neurol; 2011 Mar; 11():40. PubMed ID: 21450086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
    Drulovic J; Bursac LO; Milojkovic D; Tepavcevic DK; Gazibara T; Pekmezovic T
    Disabil Rehabil; 2013 Mar; 35(5):362-6. PubMed ID: 22897503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
    Raggi A; Giovannetti AM; Schiavolin S; Confalonieri P; Brambilla L; Brenna G; Cortese F; Covelli V; Frangiamore R; Moscatelli M; Ponzio M; Torri Clerici V; Zaratin P; Mantegazza R; Leonardi M
    Acta Neurol Scand; 2015 Oct; 132(4):226-34. PubMed ID: 25690402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study.
    Giordano A; Pucci E; Naldi P; Mendozzi L; Milanese C; Tronci F; Leone M; Mascoli N; La Mantia L; Giuliani G; Solari A
    J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):1023-8. PubMed ID: 19443471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assessed health status changes in a community cohort of people with multiple sclerosis: 11 years of follow-up.
    Giordano A; Ferrari G; Radice D; Randi G; Bisanti L; Solari A;
    Eur J Neurol; 2013 Apr; 20(4):681-8. PubMed ID: 23217086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.
    Jongen PJ; Sanders E; Zwanikken C; Koeman J; Visser LH; Koopmans P; Lehnick D;
    Patient Prefer Adherence; 2013; 7():293-300. PubMed ID: 23589682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient Empowerment.
    Jongen PJ; Ter Veen G; Lemmens W; Donders R; van Noort E; Zeinstra E
    J Med Internet Res; 2020 Mar; 22(3):e14297. PubMed ID: 32149713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study.
    Zecca C; Disanto G; Mühl S; Gobbi C
    BMC Neurol; 2017 Sep; 17(1):171. PubMed ID: 28870152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.